TRT and fertility: what HCG and Clomid can actually do for sperm count

What's this video probably claiming?

Based on the caption, this creator is likely walking viewers through one of the more legitimate corners of TRT discourse: that exogenous testosterone suppresses sperm production, but that co-administration of agents like human chorionic gonadotropin (HCG) or clomiphene citrate (Clomid) can partially or fully preserve fertility. The framing, "that's not the full story," suggests the creator is positioning themselves as correcting a common misconception, specifically the idea that TRT is a permanent fertility death sentence. That premise is directionally correct. The problem is that TikTok's format almost guarantees the nuance gets lost. What starts as a reasonable clinical point can quickly become "just take HCG and you're fine," which glosses over real variability in outcomes, the difference between azoospermia and oligospermia, and the fact that recovery after TRT is not guaranteed for every man.

What does the science actually show?

Exogenous testosterone suppresses the hypothalamic-pituitary-gonadal (HPG) axis by reducing LH and FSH secretion, which in turn shuts down intratesticular testosterone production and spermatogenesis. This is well-documented. A 2016 WHO-sponsored contraceptive trial (Gu et al., Contraception) showed that injectable testosterone effectively suppressed sperm counts below 1 million/mL in the majority of men, confirming how reliably TRT disrupts fertility.

HCG mimics LH and directly stimulates Leydig cells to maintain intratesticular testosterone, which is essential for sperm production. A study by Coviello et al. (2005, Journal of Clinical Endocrinology and Metabolism) found that adding HCG at 250 IU every other day to a testosterone regimen maintained intratesticular testosterone concentrations and preserved spermatogenesis in most subjects. Clomiphene works differently, by blocking estrogen receptors at the hypothalamus to increase endogenous LH and FSH output. It is not a perfect substitute for HCG in men already on exogenous testosterone, because exogenous T still suppresses the axis regardless of clomiphene's upstream signaling.

Where does the social media noise diverge from clinical reality?

The biggest gap between TikTok TRT content and clinical reality is the implication that HCG is a reliable on/off switch for fertility preservation. It is not that clean. Coviello's 2005 data showed maintenance of spermatogenesis in men who had not yet fully suppressed, but recovery after prolonged azoospermia on TRT is a different problem. A 2020 review by Samplaski et al. (Therapeutic Advances in Urology) found median recovery time to baseline sperm parameters after stopping TRT was around 3 to 6 months, but some men took over a year, and a subset did not fully recover.

There is also a conflation problem with Clomid. Clomiphene is a reasonable monotherapy for secondary hypogonadism because it raises endogenous testosterone without shutting down the axis. Using it alongside exogenous testosterone is pharmacologically awkward and not standard practice. Creators who bundle HCG and Clomid as equivalent "fertility-saving add-ons" to TRT are compressing two distinct clinical scenarios into one talking point, which misleads men who are trying to make real reproductive decisions.

What should you actually know?

If you are on TRT and want to preserve fertility, the evidence-backed option is HCG co-administration, typically in the range studied by Coviello and others, started before or concurrent with testosterone, not after azoospermia is already established. Waiting until sperm count is zero and then adding HCG is a harder recovery problem than preventing suppression in the first place.

If you have not started TRT yet and fertility is a near-term priority, clomiphene monotherapy is a clinically reasonable option for secondary hypogonadism. It raises testosterone, preserves the HPG axis, and maintains sperm production. The 2013 Katz et al. study (BJU International) showed clomiphene improved testosterone levels in hypogonadal men without suppressing spermatogenesis.

Any man considering TRT who wants biological children should have a baseline semen analysis done before starting, and should discuss fertility preservation explicitly with a urologist or reproductive endocrinologist, not just a telehealth platform optimizing for convenience. This video is probably helpful as a conversation starter. It should not be the last word.